LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management.

Cheung, Ka-Shing / Leung, Wai K

World journal of gastroenterology

2017  Volume 23, Issue 11, Page(s) 1954–1963

Abstract: Novel oral anticoagulants (NOACs), which include direct thrombin inhibitor (dabigatran) and direct ... including gastrointestinal bleeding (GIB). Results from both randomized clinical trials and observations ... factor Xa inhibitors (rivaroxaban, apixaban and edoxaban), are gaining popularity in the prevention ...

Abstract Novel oral anticoagulants (NOACs), which include direct thrombin inhibitor (dabigatran) and direct factor Xa inhibitors (rivaroxaban, apixaban and edoxaban), are gaining popularity in the prevention of embolic stroke in non-valvular atrial fibrillation as well as in the prevention and treatment of venous thromboembolism. However, similar to traditional anticoagulants, NOACs have the side effects of bleeding, including gastrointestinal bleeding (GIB). Results from both randomized clinical trials and observations studies suggest that high-dose dabigatran (150 mg b.i.d), rivaroxaban and high-dose edoxaban (60 mg daily) are associated with a higher risk of GIB compared with warfarin. Other risk factors of NOAC-related GIB include concomitant use of ulcerogenic agents, older age, renal impairment,
MeSH term(s) Administration, Oral ; Anticoagulants/administration & dosage ; Anticoagulants/adverse effects ; Anticoagulants/therapeutic use ; Atrial Fibrillation/prevention & control ; Blood Coagulation Factors/agonists ; Blood Coagulation Factors/antagonists & inhibitors ; Clinical Trials as Topic ; Endoscopy, Gastrointestinal ; Gastrointestinal Hemorrhage/chemically induced ; Gastrointestinal Hemorrhage/prevention & control ; Gastrointestinal Hemorrhage/therapy ; Helicobacter Infections/complications ; Humans ; Peptic Ulcer/chemically induced ; Peptic Ulcer/complications ; Risk Factors ; Stroke/prevention & control
Chemical Substances Anticoagulants ; Blood Coagulation Factors
Language English
Publishing date 2017-02-11
Publishing country United States
Document type Journal Article ; Review
ZDB-ID 2185929-2
ISSN 2219-2840 ; 1007-9327
ISSN (online) 2219-2840
ISSN 1007-9327
DOI 10.3748/wjg.v23.i11.1954
Shelf mark
Zs.A 6039: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top